Financial and Investment Analysts H-1B salary at BioMarin Pharmaceutical Inc.: $85,966 average ($85,966-$85,966 range). 100% approval rate.
BioMarin Pharmaceutical Inc. has sponsored 1 H-1B petition for Financial and Investment Analysts roles. The average offered salary of $86k is 0% above the prevailing wage for this occupation. Most positions are located in California (100%). The certification rate is 100%. 100% of these filings are for new employment.
| Total Filings | 1 |
| Approval Rate | 100% |
| Average Salary | $85,966 |
| Median Salary | $85,966 |
| 25th Percentile | $85,966 |
| 75th Percentile | $85,966 |
| Minimum Salary | $85,966 |
| Maximum Salary | $85,966 |
0% of filings offer salaries above the prevailing wage, with an average premium of 0%. The average prevailing wage is $86k (based on 1 filings with prevailing wage data).
Average processing time is 7 days (median: 7 days). Fastest: 7 days, slowest: 7 days. Based on 1 filings.
100% of filings are for new positions, while 0% are for continued employment (1 filings with data).
Average contract duration: 36 months (median: 36 months), based on 1 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 1 |
| State | Filings |
|---|---|
| California | 1 |
BioMarin Pharmaceutical Inc. has 1 H-1B filings for Financial and Investment Analysts positions in our database of DOL public records.
The average H-1B salary for Financial and Investment Analysts at BioMarin Pharmaceutical Inc. is $85,966, with a median of $85,966. Salaries range from $85,966 to $85,966.
The H-1B approval rate for Financial and Investment Analysts positions at BioMarin Pharmaceutical Inc. is 100% based on 1 DOL filings.
See how Financial and Investment Analysts salaries compare across different H-1B sponsors.